Bio-Techne Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 6/6
Bio-Techne şirketinin toplam hissedar öz sermayesi $2.1B ve toplam borcu $300.0M olup, bu da borç-öz sermaye oranını 14% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $2.7B ve $597.4M dir. Bio-Techne 'in FAVÖK'ü $243.8M faiz karşılama oranı 25.2 dur. Şirketin $187.5M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.
Anahtar bilgiler
14.0%
Borç/özkaynak oranı
US$300.00m
Borç
| Faiz karşılama oranı | 25.2x |
| Nakit | US$187.54m |
| Eşitlik | US$2.14b |
| Toplam yükümlülükler | US$597.37m |
| Toplam varlıklar | US$2.74b |
Son finansal sağlık güncellemeleri
Is Bio-Techne (NASDAQ:TECH) A Risky Investment?
Sep 26
These 4 Measures Indicate That Bio-Techne (NASDAQ:TECH) Is Using Debt Reasonably Well
Apr 30We Think Bio-Techne (NASDAQ:TECH) Can Stay On Top Of Its Debt
Jan 17Bio-Techne (NASDAQ:TECH) Has A Rock Solid Balance Sheet
Sep 22Does Bio-Techne (NASDAQ:TECH) Have A Healthy Balance Sheet?
Jun 22Bio-Techne (NASDAQ:TECH) Has A Rock Solid Balance Sheet
Mar 21Recent updates
There May Be Reason For Hope In Bio-Techne's (NASDAQ:TECH) Disappointing Earnings
Nov 06Is Bio-Techne (NASDAQ:TECH) A Risky Investment?
Sep 26Why Bio-Techne Corporation (NASDAQ:TECH) Could Be Worth Watching
Sep 11Bio-Techne Corporation's (NASDAQ:TECH) Price In Tune With Earnings
Aug 24When Should You Buy Bio-Techne Corporation (NASDAQ:TECH)?
Jun 09Bio-Techne Corporation's (NASDAQ:TECH) Shares Climb 33% But Its Business Is Yet to Catch Up
May 21These 4 Measures Indicate That Bio-Techne (NASDAQ:TECH) Is Using Debt Reasonably Well
Apr 30Bio-Techne Corporation (NASDAQ:TECH) Shares Could Be 32% Above Their Intrinsic Value Estimate
Apr 15Bio-Techne: Secular Growth Opportunities Always Exhibit Financial Excellence
Apr 04We Think Bio-Techne (NASDAQ:TECH) Can Stay On Top Of Its Debt
Jan 17Bio-Techne Corporation (NASDAQ:TECH) Investors Are Less Pessimistic Than Expected
Dec 30Estimating The Intrinsic Value Of Bio-Techne Corporation (NASDAQ:TECH)
Dec 05Is Now An Opportune Moment To Examine Bio-Techne Corporation (NASDAQ:TECH)?
Oct 10Bio-Techne (NASDAQ:TECH) Has A Rock Solid Balance Sheet
Sep 22A Look At The Intrinsic Value Of Bio-Techne Corporation (NASDAQ:TECH)
Sep 01At US$80.80, Is Bio-Techne Corporation (NASDAQ:TECH) Worth Looking At Closely?
Jul 10Does Bio-Techne (NASDAQ:TECH) Have A Healthy Balance Sheet?
Jun 22With EPS Growth And More, Bio-Techne (NASDAQ:TECH) Makes An Interesting Case
Jun 07Bio-Techne Corporation's (NASDAQ:TECH) Intrinsic Value Is Potentially 25% Below Its Share Price
May 23When Should You Buy Bio-Techne Corporation (NASDAQ:TECH)?
Apr 05Bio-Techne (NASDAQ:TECH) Has A Rock Solid Balance Sheet
Mar 21Here's Why We Think Bio-Techne (NASDAQ:TECH) Is Well Worth Watching
Mar 06When Should You Buy Bio-Techne Corporation (NASDAQ:TECH)?
Jan 03We Think Bio-Techne (NASDAQ:TECH) Can Manage Its Debt With Ease
Dec 15Should You Be Adding Bio-Techne (NASDAQ:TECH) To Your Watchlist Today?
Nov 30Estimating The Intrinsic Value Of Bio-Techne Corporation (NASDAQ:TECH)
Nov 17Bio-Techne releases new AVV viral titer assays
Oct 11At US$291, Is Bio-Techne Corporation (NASDAQ:TECH) Worth Looking At Closely?
Sep 26Does Bio-Techne (NASDAQ:TECH) Have A Healthy Balance Sheet?
Sep 12Bio-Techne to seek shareholder approval for 4- for-1 stock split
Sep 01Is Now The Time To Put Bio-Techne (NASDAQ:TECH) On Your Watchlist?
Aug 29Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: TECH 'nin kısa vadeli varlıkları ( $648.6M ) kısa vadeli yükümlülüklerini ( $142.1M ) aşıyor.
Uzun Vadeli Yükümlülükler: TECH şirketinin kısa vadeli varlıkları ( $648.6M ) uzun vadeli yükümlülüklerini ( $455.2M ) aşmaktadır.
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: TECH 'nin net borç/öz sermaye oranı ( 5.3% ) tatmin edici olarak değerlendirilmektedir.
Borcun Azaltılması: TECH 'nin borç/öz sermaye oranı son 5 yılda 42.5% seviyesinden 14% seviyesine düştü.
Borç Kapsamı: TECH 'nin borcu işletme nakit akışı ( 101.2% ) tarafından iyi bir şekilde karşılanmaktadır.
Faiz Kapsamı: TECH 'in borcuna ilişkin faiz ödemeleri EBIT ( 25.2 x kapsam) tarafından iyi bir şekilde karşılanmaktadır.